- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01114269
PŘEDBĚŽNÉ URČENÍ kohortové studie
PŘEDBĚŽNÉ STANOVENÍ: Kohortová studie biologických markerů a MRI SCD
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
Přehled studie
Postavení
Detailní popis
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
Alberta
-
Edmonton, Alberta, Kanada, T6G 2B7
- University of Alberta
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 1M9
- Vancouver General Hospital
-
-
Ontario
-
Mississauga, Ontario, Kanada, L5B 2P7
- Mississauga Clinical Research Centre
-
-
-
-
-
Rio Piedras, Portoriko, 00924
- Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
-
-
-
-
Alaska
-
Anchorage, Alaska, Spojené státy, 99508
- Alaska Heart Institute
-
-
Arizona
-
Glendale, Arizona, Spojené státy, 85306
- Phoenix Heart, PLLC
-
Phoenix, Arizona, Spojené státy, 85032
- Cardiovascular Consultants
-
-
California
-
Banning, California, Spojené státy, 92220
- Beaver Medical Group/Clinical Care Research
-
-
Colorado
-
Colorado Springs, Colorado, Spojené státy, 80909
- Memorial Health System
-
Denver, Colorado, Spojené státy, 80204
- Colorado Heart and Vascular
-
-
Florida
-
Brandon, Florida, Spojené státy, 33511
- Bay Area Cardiology Associates, P.A.
-
Gainesville, Florida, Spojené státy, 32610
- University of Florida - Gainsville
-
Miami, Florida, Spojené státy, 33135
- Reliable Clinical Research
-
Miami Beach, Florida, Spojené státy, 33140
- Mount Sinai Medical Center
-
Orlando, Florida, Spojené státy, 32804
- Florida Hospital
-
Orlando, Florida, Spojené státy, 32806
- Orlando Regional Medical Center
-
Palm Beach Gardens, Florida, Spojené státy, 33410
- Palm Beach Gardens Research Center
-
Sarasota, Florida, Spojené státy, 34233
- Velella Research
-
Tallahassee, Florida, Spojené státy, 32308
- Tallahassee Research Institute, Inc.
-
West Palm Beach, Florida, Spojené státy, 33401
- Cardiology Associates of Palm Beach - West Palm Beach
-
-
Georgia
-
Covington, Georgia, Spojené státy, 30014
- Georgia Heart Specialist
-
Gainesville, Georgia, Spojené státy, 30501
- Northeast Georgia Heart Center, P.C.
-
-
Illinois
-
Chicago, Illinois, Spojené státy, 60637
- University of Chicago
-
Chicago, Illinois, Spojené státy, 60643
- Advocate Medical Group
-
Chicago, Illinois, Spojené státy, 60657
- Advocate Medical Group - Heart and Vascular of IL
-
Melrose Park, Illinois, Spojené státy, 60160
- Consultants in Cardiovascular Medicine
-
-
Indiana
-
Anderson, Indiana, Spojené státy, 46011
- Community Heart and Vascular
-
-
Iowa
-
West Des Moines, Iowa, Spojené státy, 50266
- Iowa Heart Center
-
-
Kansas
-
Kansas City, Kansas, Spojené státy, 66160
- The University of Kansas
-
-
Kentucky
-
Lexington, Kentucky, Spojené státy, 40503
- Baptist Health Lexington
-
-
Louisiana
-
Houma, Louisiana, Spojené státy, 70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Auburn, Maine, Spojené státy, 04210
- Maine Research Associates
-
Lewiston, Maine, Spojené státy, 04240
- Maine Research Associates - Lewiston
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Ayer, Massachusetts, Spojené státy, 01432
- Primary Care Cardiology Research
-
Boston, Massachusetts, Spojené státy, 02115
- Brigham and Women's Hospital
-
Fall River, Massachusetts, Spojené státy, 02720
- NECCR Internal Medicine and Cardiology Associates, LLC
-
North Dartmouth, Massachusetts, Spojené státy, 02747
- Hawthorn Medical Associates
-
Springfield, Massachusetts, Spojené státy, 01199
- Baystate Cardiology
-
-
Michigan
-
Ann Arbor, Michigan, Spojené státy, 48109
- University of Michigan Medical Center
-
Dearborn, Michigan, Spojené státy, 48124
- Oakwood Hospital & Medical Center
-
Mount Clemens, Michigan, Spojené státy, 48043
- McLaren Medical Center - Macomb
-
Ypsilanti, Michigan, Spojené státy, 48197
- Michigan Heart
-
-
Minnesota
-
Minneapolis, Minnesota, Spojené státy, 55417
- Minneapolis VA Medical Center
-
-
Missouri
-
Columbia, Missouri, Spojené státy, 65201
- University of Missouri Health Care
-
-
Montana
-
Kalispell, Montana, Spojené státy, 59901
- Glacier View Cardiology
-
-
Nebraska
-
Omaha, Nebraska, Spojené státy, 68131
- The Cardiac Center of Creighton University
-
-
New Jersey
-
Bridgewater, New Jersey, Spojené státy, 08807
- Advanced Heartcare, LLC
-
Paterson, New Jersey, Spojené státy, 07503
- St. Joseph Regional Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Spojené státy, 87108
- New Mexico VA Healthcare Systems
-
-
New York
-
Albany, New York, Spojené státy, 12205
- Albany Associates Cardiology
-
Brooklyn, New York, Spojené státy, 11219
- Maimonides Medical Center
-
Buffalo, New York, Spojené státy, 14203
- Buffalo General Hospital/Kaleida Health
-
Jamaica, New York, Spojené státy, 11418
- Jamaica Hospital Medical Center
-
Kingston, New York, Spojené státy, 12401
- Mid-Valley Cardiology
-
Mineola, New York, Spojené státy, 11501
- Winthrop-University Hospital
-
New York, New York, Spojené státy, 10001
- Gotham Cardiovascular
-
New York, New York, Spojené státy, 10032
- Columbia University Health Center
-
Stony Brook, New York, Spojené státy, 11794
- Stony Brook University Medical Center
-
Utica, New York, Spojené státy, 13501
- St. Elizabeth Medical Center - Hotvedt
-
-
North Carolina
-
Asheville, North Carolina, Spojené státy, 28801
- Asheville Cardiology Associates
-
Elizabeth City, North Carolina, Spojené státy, 27909
- Eastern Carolina Cardiovascular
-
Lenoir, North Carolina, Spojené státy, 28645
- Northstate Clinical Research
-
Pinehurst, North Carolina, Spojené státy, 28374
- Pinehurst Medical Clinic, Inc.
-
Sanford, North Carolina, Spojené státy, 27330
- Sanford Cardiology
-
Winston-Salem, North Carolina, Spojené státy, 27157
- Wake Forest
-
-
Ohio
-
Akron, Ohio, Spojené státy, 44304
- Northeast Ohio Cardiovascular Specialists
-
Cincinnati, Ohio, Spojené státy, 45267
- University of Cincinnati
-
Cleveland, Ohio, Spojené státy, 44109
- MetroHealth Medical Center
-
Elyria, Ohio, Spojené státy, 44035
- North Ohio Research, Ltd.
-
Fairfield, Ohio, Spojené státy, 45014
- Mercy Medical Associates
-
Toledo, Ohio, Spojené státy, 43615
- Northwest Ohio Cardiology Consultants/The Toledo Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Spojené státy, 73120
- Oklahoma Foundation for Cardiovascular Research
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- Oklahoma City VA Medical Center Veterans Research and Education Foundation
-
-
Pennsylvania
-
Abington, Pennsylvania, Spojené státy, 19001
- Abington Memorial Hospital
-
Bethlehem, Pennsylvania, Spojené státy, 18018
- St. Luke's Bethlehem
-
Doylestown, Pennsylvania, Spojené státy, 18901
- Doylestown Cardiology Associates
-
Pittsburgh, Pennsylvania, Spojené státy, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Spojené státy, 15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Anderson, South Carolina, Spojené státy, 29621
- AnMed Health
-
Charleston, South Carolina, Spojené státy, 29425
- VA Medical Center - Charleston
-
Rock Hill, South Carolina, Spojené státy, 29732
- Carolina Cardiology Associates
-
-
South Dakota
-
Rapid City, South Dakota, Spojené státy, 57701
- Black Hills Cardiovascular Research
-
-
Tennessee
-
Knoxville, Tennessee, Spojené státy, 37917
- Cardiovasular Research of Knoxville
-
Memphis, Tennessee, Spojené státy, 38104
- Memphis VA Medical Center
-
-
Texas
-
Houston, Texas, Spojené státy, 77030
- St. Luke's Episcopal Hospital
-
Houston, Texas, Spojené státy, 77074
- Non-Invasive Cardiovascular PA
-
Waco, Texas, Spojené státy, 76712
- Providence Health Center
-
-
Utah
-
Murray, Utah, Spojené státy, 84157
- Intermountain Medical Center
-
-
Virginia
-
Virginia Beach, Virginia, Spojené státy, 23454
- Cardiovascular Associates Virginia Beach
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
Popis
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
- Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
- Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
-
MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
- Symptoms of Ischemia
- ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
- Development of pathological Q waves
- Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
-
-
Exclusion Criteria:
- History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
- Unexplained syncope
- Current or planned implantable cardiac defibrillator (ICD)
- Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
- Metastatic cancer
- Marked valvular heart disease requiring surgical intervention
- Current or planned cardiac, renal or liver transplant
- Current alcohol or drug abuse
- Unwilling or unable to provide informed consent
- LVEF <35% with Class II-IV CHF or LVEF <30%
- Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: COHORT
- Časové perspektivy: PROSPECTIVE
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
Časové okno: Median follow-up estimated to be 10.7 years
|
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation. |
Median follow-up estimated to be 10.7 years
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Implantace ICD
Časové okno: Střední doba sledování se odhaduje na 10,7 let
|
Střední doba sledování se odhaduje na 10,7 let
|
|
|
Celková srdeční úmrtnost
Časové okno: Střední doba sledování se odhaduje na 10,7 let
|
Střední doba sledování se odhaduje na 10,7 let
|
|
|
Úplná úmrtnost
Časové okno: Střední doba sledování se odhaduje na 10,7 let
|
Střední doba sledování se odhaduje na 10,7 let
|
|
|
ICD Shock
Časové okno: Median follow-up estimated to be 10.7 years
|
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint. |
Median follow-up estimated to be 10.7 years
|
|
Non-Sudden or Arrhythmic Causes of Mortality
Časové okno: Median follow-up estimated to be 10.7 years
|
Competing causes of mortality in competing risk analyses. |
Median follow-up estimated to be 10.7 years
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital
Publikace a užitečné odkazy
Obecné publikace
- Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. JACC Clin Electrophysiol. 2020 Jan;6(1):70-79. doi: 10.1016/j.jacep.2019.08.011. Epub 2019 Oct 30.
- Lee DC, Albert CM, Narula D, Kadish AH, Panicker GK, Wu E, Schaechter A, Pester J, Chatterjee NA, Cook NR, Goldberger JJ. Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score. J Am Heart Assoc. 2020 Feb 4;9(3):e014205. doi: 10.1161/JAHA.119.014205. Epub 2020 Jan 24.
- Chatterjee NA, Tikkanen JT, Panicker GK, Narula D, Lee DC, Kentta T, Junttila JM, Cook NR, Kadish A, Goldberger JJ, Huikuri HV, Albert CM; PREDETERMINE Investigators. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
- Panicker GK, Narula DD, Albert CM, Lee DC, Kothari S, Goldberger JJ, Cook N, Schaechter A, Kim E, Moorthy MV, Pester J, Chatterjee NA, Kadish AH, Karnad DR. Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12812. doi: 10.1111/anec.12812. Epub 2020 Oct 30.
- Venkateswaran RV, Moorthy MV, Chatterjee NA, Pester J, Kadish AH, Lee DC, Cook NR, Albert CM. Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. JACC Clin Electrophysiol. 2021 Dec;7(12):1604-1614. doi: 10.1016/j.jacep.2021.05.014. Epub 2021 Jul 28.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
- Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
- Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxen J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts. Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM; PRE-DETERMINE Study Group. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhadovaný)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Cévní onemocnění
- Kardiovaskulární choroby
- Patologické procesy
- Srdeční choroba
- Smrt
- Infarkt
- Nekróza
- Ventrikulární dysfunkce
- Arterioskleróza
- Arteriální okluzivní onemocnění
- Koronární onemocnění
- Ischémie myokardu
- Ischemie
- Srdeční zástava
- Smrt, Náhle
- Patologické stavy, příznaky a symptomy
- Dysfunkce komory, levá
- Ischemická choroba srdeční
- Smrt, náhlá, srdeční
- Infarkt myokardu
Další identifikační čísla studie
- 2007P000840
- R01HL091069 (Grant/smlouva NIH USA)
- R01HL165840 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .